0001140361-17-034317.txt : 20170905
0001140361-17-034317.hdr.sgml : 20170904
20170905165051
ACCESSION NUMBER: 0001140361-17-034317
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170831
FILED AS OF DATE: 20170905
DATE AS OF CHANGE: 20170905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hershberger Michael D
CENTRAL INDEX KEY: 0001569128
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35811
FILM NUMBER: 171069278
MAIL ADDRESS:
STREET 1: C/O HEALTH INSURANCE INNOVATIONS, INC.
STREET 2: 15438 N. FLORIDA AVENUE, SUITE 201
CITY: TAMPA
STATE: FL
ZIP: 33613
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Health Insurance Innovations, Inc.
CENTRAL INDEX KEY: 0001561387
STANDARD INDUSTRIAL CLASSIFICATION: INSURANCE AGENTS BROKERS & SERVICES [6411]
IRS NUMBER: 461282634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15438 N. FLORIDA AVENUE
STREET 2: SUITE 201
CITY: TAMPA
STATE: FL
ZIP: 33613
BUSINESS PHONE: 813-397-1187
MAIL ADDRESS:
STREET 1: 15438 N. FLORIDA AVENUE
STREET 2: SUITE 201
CITY: TAMPA
STATE: FL
ZIP: 33613
4
1
doc1.xml
FORM 4
X0306
4
2017-08-31
0
0001561387
Health Insurance Innovations, Inc.
HIIQ
0001569128
Hershberger Michael D
C/O HEALTH INSURANCE INNOVATIONS, INC.
15438 NORTH FLORIDA AVE., SUITE 201
TAMPA
FL
33613
0
1
0
0
CFO, Secretary and Treasurer
Class A Common Stock
2017-08-31
4
S
0
2500
34.8066
D
94569
D
Class A Common Stock
2017-09-01
4
S
0
400
28.3625
D
94169
D
Class A Common Stock
2017-09-01
4
S
0
3300
29.0990
D
90869
D
Class A Common Stock
2017-09-01
4
S
0
100
30.45
D
90769
D
Class A Common Stock
2017-09-01
4
S
0
800
32.0875
D
89969
D
Class A Common Stock
2017-09-01
4
S
0
400
33.7375
D
89569
D
Class A Common Stock
2017-09-01
4
M
0
15000
10.45
A
104569
D
Class A Common Stock
2017-09-01
4
D
0
4659
28.965
D
99910
D
Class A Common Stock
2017-09-01
4
S
0
3597
28.965
D
96313
D
Class A Common Stock
2017-09-01
4
M
0
15000
4.95
A
111313
D
Class A Common Stock
2017-09-01
4
D
0
2207
32.0163
D
109106
D
Class A Common Stock
2017-09-01
4
S
0
4450
32.0163
D
104656
D
Class A Common Stock
2017-09-01
4
M
0
7500
4.99
A
112156
D
Class A Common Stock
2017-09-01
4
D
0
1113
33.8103
D
111043
D
Class A Common Stock
2017-09-01
4
S
0
2222
33.8103
D
108821
D
Stock Appreciation Rights
10.45
2017-09-01
4
M
0
15000
0
D
2021-05-21
Common Stock
15000
10000
D
Stock Appreciation Rights
4.95
2017-09-01
4
M
0
15000
0
D
2022-07-01
Common Stock
15000
15000
D
Stock Appreciation Rights
4.99
2017-09-01
4
M
0
7500
0
D
2022-09-16
Common Stock
7500
22500
D
Stock Appreciation RIghts
5.2
2023-09-16
Common Stock
40972
40972
D
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.75 to $34.90, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Sale made pursuant to 10b5-1 plan executed on November 18, 2016.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.85 to $28.70, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.0990, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.90 to $32.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.65 to $33.80, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
These stock-settled stock appreciation rights were granted under the Long Term Incentive Plan of Health Insurance Innovations, Inc. (the "Plan") and vest 20% on the first three anniversaries of grant date and 40% on the fourth anniversary, subject to the terms of the Plan and an award agreement under the Plan.
These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first and second anniversaries of grant date and 50% on the third anniversary, subject to the terms of the Plan and an award agreement under the Plan.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.90 to $29.00, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.15, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.80 to $33.90, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
/s/ Michael D. Hershberger
2017-09-05